Burjeel Sukuk Draws $1.6 Billion Order Book For AI Healthcare Plans
Burjeel Holdings listed a $500 million sukuk on the London Stock Exchange after a $1.6 billion order book, but did not name the AI healthcare projects or digital budget tied to the proceeds.

Burjeel said its $500 million sukuk drew a $1.6 billion order book before listing on the London Stock Exchange, with proceeds earmarked for expansion, digital transformation and AI-enabled healthcare work.
Burjeel Holdings Lists $500 Million Sukuk On London Stock Exchange
Burjeel said the listing marked its first entry into international debt capital markets.
The sukuk was admitted to trading on the International Securities Market after completion of an issuance under its $1.5 billion Senior Unsecured Sukuk Program.
UAE diplomatic representation was present at the London ceremony, along with Burjeel chairman and chief executive Dr. Shamsheer Vayalil, company leaders and London Stock Exchange representatives.
Burjeel said the issuance was its first international debt-market fundraising.
It also described the deal as the first MENA healthcare-provider sukuk since 2018, and said proceeds will refinance existing debt and support strategic expansion plans.
Order Book Reached $1.6 Billion For The Healthcare Issuance
Burjeel said demand equalled 3.2 times the issue size.
The company also said international investors accounted for 61 percent of the final allocation.
Those figures put the transaction in a capital-markets frame rather than a simple healthcare announcement.
The disclosed investor demand gives Burjeel funding flexibility while it expands its regional healthcare network and invests in medical technology, education and research.
Vayalil said the listing gives Burjeel a stronger foundation for investing in healthcare professionals, specialised services, research, education and innovation across the region.
Burjeel also said the proceeds will fund digital transformation and AI-enabled healthcare innovation alongside advanced clinical care, medical research and healthcare education.
Ratings Agencies Assigned BB+ And Ba2 Grades
Burjeel said S&P Global Ratings assigned the sukuk a BB+ rating, while Moody's Ratings assigned a Ba2 rating.
The company said the ratings reflected confidence in its business fundamentals, operating model and long-term growth prospects.
The sukuk gives Burjeel a debt-market instrument tied to healthcare growth, but the digital and AI part of the use of proceeds remains broad.
Burjeel did not name specific AI healthcare projects, disclose the digital transformation budget, identify technology suppliers, or provide deployment dates for the investments funded by the sukuk.


















